Synthesis of ether-linked analogues of lysophosphatidate and their effect on the proliferation of human epithelial cancer cells in vitro

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 1813-1818

  Ashagbley, Anthony ^a   Samadder, Pranati ^a   Bittman, Robert ^b   Erukulla, Ravi Kumar ^b   Byun, Hoe Sup ^b   Arthur, Gilbert ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Alkyllysophospholipid; Antitumor ether lipids; Epithelial cancer cells; Lysophosphatidate

Indexed keywords

1 O HEXADECYL 2 O METHYL SN GLYCERO 3 PHOSPHATE; 1 OLEOYL 2 LYSOPHOSPHATIDATE; 4 O HEXADECYL 3 O METHOXYBUTANEPHOSPHONATE; 4 THIOHEXADECYL 3 O METHOXYBUTANE 4 PHOSPHATE; ALKYLLYSOPHOSPHOLIPID; EDELFOSINE; LYSOPHOSPHATIDIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOMA; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; KIDNEY CANCER; LUNG CANCER; NEUROBLASTOMA; PRIORITY JOURNAL; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHERS; FEMALE; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; LYSOPHOSPHOLIPIDS; MALE; NEUROBLASTOMA; PHOSPHONIC ACIDS; PROSTATIC NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0029764223     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lohmeyer M and Bittman R: Antitumor ether lipids and alkylphosphocholines. Drugs of the Future 19: 1021-1037, 1994.
2. Berdel WE: A Membrane-interactive lipids as experimental anticancer drugs. Br J Cancer 64: 208-211, 1991.
3. Lu X, Rengan K, Bittman R and Arthur G: The α and ß anomers of 1-O-hexadecyl-2-O-methyl-3-S-thioglucosyl-sn-glycerol inhibit the proliferation of epithelial cancer cell lines. Oncology Reports 1: 933-936, 1994.
4. Kudo I, Nojima S, Chang HW, Yanoshita R, Hayashi H, Kondo E, Nomura H, and Inoue K: Antitumor activity of synthetic alkylphospholipids with or without PAF activity. Lipids 22: 862-867, 1987.
5. Noseda A, Berens ME, Piantadosi C and Modest E: Neoplastic cell inhibition with new ether lipid analogues. Lipids 22: 878-883, 1987.
6. Ukawa K, Imamiya E, Yamamoto H, Aono T, Kozai Y, Okutani T, Nomura H, Honma Y, Hozumi M, Kudo I and Inoue K: 1989. Synthesis and antitumor activity of new amphiphilic alkylglvcerolipids substituted with a polar head group. 2-(2-trimethylammonioethoxy)ethyl or a congeneric oligo(ethyleneoxy)ethyl group. Chem Pharm Bull 37: 3277-3285. 1989.
7. Tsushima S, Yoshioka Y, Tanida S, Nomura H, Nojima S and Hozumi M: Synthesis and biological activities of N-alkyl- and N-alkenylcarbamoyl phospholipids. Chem Pharm Bull 32: 2700-2713. 1984.
8. Powis G: 1991. Signalling targets for anticancer drug development. Trends Pharm Sci 12: 188-194.
9. Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, and Modest EJ: Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res 52, 2835-2840, 1992.
10. Berggren MI, Gallegos A, Dressier LA, Modest EJ and G. Powis G: Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Cancer Res 53: 4297-4302, 1993.
11. Kosano H, Yasutomo Y, Kugai N, Nagata N, Inagaki H, Tanaka S and Takatani O: Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyllysophospholipid. Cancer Res 50: 3172-3175, 1990.
12. Moolenaar WH: Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 270: 12949-12952, 1995.
13. Bittman R, Byun H-S, Mercier B and Salari H: Isosteric phosphonate analogues of ET-16-OMc. Synthesis and biological evaluation of the cnantiomcrs of 2′-(trimethylammonio)ethyl-4-(hexadecyloxy)-3-methoxybutanephosphonate and 2′-(trimethyl-ammonio)ethyl-4-(hexadecylthio)-3-methoxybutanephosphonate. J Med Chem 37: 425-430, 1994.
14. Byun H-S, Kumar ER and Bittman R: Enantioselective synthesis of 1-O-benzyl-sn-glycerol and 1-O-hexadecyl-2-O-methyl-sn-glycerol via asymmetric dihydroxylation of allyl 4-methoxyphenyl ether. Use of AD-mix supplemented with potassium persulfate. J Org Chem 59: 2630-2633.
15. Zhou X, Lu X and Arthur G: Relationship between cellular glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine. Anticancer Res 12: 1659-1662, 1992.
16. Van Corven EJ, Groenink A, Jalink K, Eichholtz T and Moolenaar WH: Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins. Cell 59: 45-54, 1989.
17. Bittman R, Byun H-S, Mercier B and Salari H: 2′-(Trimethylammonio)ethyl 4-(hexadecyloxy)-3-(S)-methoxybutane-phosphonate: A novel antineoplastic agent. J Med Chem 36: 297-299, 1993.
18. Brachwitz H, Langen P, Arndt D and Fichtner I: Cytostatic activity of synthetic O-alkylglycerolipids. Lipids 22: 897-903, 1987.
19. Lu X, Zhou X, Kardash D and Arthur G: Metabolism of alkyllysophospholipid in epithelial cancer cell lines and inhibition of cell growth. Biochem. Cell Biol 71:122-126, 1993.
20. Herrmann DBJ, and Neumann HB: Cytotoxic activity of thioether phospholipid analogue BM 41.440 in primary human tumor cultures. Lipids 22: 955-957, 1987.
21. Fromm M, Berdel WE, Schick HD, Fink U, Pahlke W, Bicker U, Reichert A and Rastetter J: Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro. Lipids 22: 916-918, 1987.